Evidence map›Paper›PMID 31396083›Full record

ReviewFrontiers in pharmacology2019

Qian Ran, Jin Wang, Lin Wang, Hai-Rong Zeng, Xiang-Bo Yang, Qin-Wan Huang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Discovery of Obacunone as a TGR5 Agonist fromInternational journal of molecular sciences · 2026
    Article
  5. Hyperhidrosis Improved by Samhwangsasim-Tang: A Case Report.Clinical, cosmetic and investigational dermatology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Discovery of Nine Dipeptidyl Peptidase-4 Inhibitors fromMolecules (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Qian RanCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Jin WangCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Lin WangCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Hai-Rong ZengCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Xiang-Bo YangYa'an Xun Kang Pharmaceutical Co., Ltd, Ya'an, China.
Qin-Wan HuangCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Chengdu University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus, especially type 2 diabetes mellitus (T2DM), has become a significant public health burden.

Indexed as

complicationsethnopharmacologyHuang LianRhizoma coptidistype 2 diabetes mellitus

Identifiers

PMID31396083
PMCPMC6661542
OpenAlexW2962914460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.